The relationship between tumor blood flow, angiogenesis, tumor hypoxia, and aerobic glycolysis

Leif Ostergaard1, Anna Tietze, Thomas Nielsen

  • 1Authors' Affiliations: Center of Functionally Integrative Neuroscience and MINDLab, Department of Clinical Medicine, Aarhus University, Aarhus Denmark; Department of Neuroradiology, and Department of Experimental Clinical Oncology, Aarhus University Hospital, Aarhus, Denmark.

Cancer Research
|June 15, 2013
PubMed

Insights

Antiangiogenic therapies impact tumor oxygenation, with results depending on capillary transit time heterogeneity (CTH). Normalizing CTH may improve drug delivery and treatment efficacy in tumors.

Area of Science:

  • Oncology
  • Physiology
  • Biomedical Engineering

Background:

  • Antiangiogenic therapies aim to starve tumors by limiting blood supply.
  • Contradictory findings exist regarding their effect on tumor oxygenation, challenging current understanding.
  • Tumor microvasculature exhibits chaotic characteristics, potentially affecting molecular transport.

Purpose of the Study:

  • To review the extended flow-diffusion equation incorporating capillary transit time heterogeneity (CTH).
  • To analyze the impact of CTH on oxygen, glucose, and cytotoxic molecule extraction in tumors.
  • To evaluate how antiangiogenic therapy influences CTH and subsequent molecular delivery.

Main Methods:

  • Review of the extended flow-diffusion equation.
  • Analysis of the relationship between blood flow, CTH, and molecular extraction.
  • Modeling of tumor physiology under antiangiogenic treatment.

Main Results:

  • Elevated CTH in tumors reduces the net extraction of oxygen, glucose, and cytotoxic agents.
  • Antiangiogenic therapy's effect on molecular extraction is contingent on CTH normalization.
  • Differential effects of CTH on oxygen and glucose extraction are observed, potentially explaining the Warburg effect.

Conclusions:

  • Capillary transit time heterogeneity (CTH) is a critical factor in tumor physiology and drug delivery.
  • Antiangiogenic therapy efficacy is linked to its ability to normalize tumor CTH.
  • The Warburg effect may be an adaptive response to high CTH in tumor microvasculature.

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
Oxygen Transport in the Blood01:27

Oxygen Transport in the Blood

Hemoglobin (Hb) is a crucial molecule in the human body, consisting of four polypeptide chains, each bound to an iron-containing heme group. This unique structure enables hemoglobin to bind to oxygen, with each molecule capable of combining with four molecules of oxygen, leading to rapid and reversible oxygen loading. When fully loaded with oxygen, it is called oxyhemoglobin, while hemoglobin that has released oxygen is called reduced hemoglobin or deoxyhemoglobin. As hemoglobin binds oxygen,...